RPL17 and head and neck squamous cell carcinoma: observed that the co-administration of anti-PD-1 and anti-TIM-3 treatment significantly enhanced the expression of CD8+ T cell cytotoxic cytokines, particularly in HNSCC patients with high circE7 expression [87].